Literature DB >> 36070064

Radiological assessment of dementia: the Italian inter-society consensus for a practical and clinically oriented guide to image acquisition, evaluation, and reporting.

Francesca B Pizzini1, Enrico Conti2, Angelo Bianchetti3,4,5, Alessandra Splendiani6, Domenico Fusco7, Ferdinando Caranci8, Alessandro Bozzao9, Francesco Landi7, Nicoletta Gandolfo10, Lisa Farina11, Vittorio Miele12, Marco Trabucchi4,5,13, Giovanni B Frisoni14, Stefano Bastianello11,15.   

Abstract

BACKGROUND: Radiological evaluation of dementia is expected to increase more and more in routine practice due to both the primary role of neuroimaging in the diagnostic pathway and the increasing incidence of the disease. Despite this, radiologists often do not follow a disease-oriented approach to image interpretation, for several reasons, leading to reports of limited value to clinicians. In our work, through an intersocietal consensus on the main mandatory knowledge about dementia, we proposed a disease-oriented protocol to optimize and standardize the acquisition/evaluation/interpretation and reporting of radiological images. Our main purpose is to provide a practical guideline for the radiologist to help increase the effectiveness of interdisciplinary dialogue and diagnostic accuracy in daily practice.
RESULTS: We defined key clinical and imaging features of the dementias (A), recommended MRI protocol (B), proposed a disease-oriented imaging evaluation and interpretation (C) and report (D) with a glimpse to future avenues (E). The proposed radiological practice is to systematically evaluate and score atrophy, white matter changes, microbleeds, small vessel disease, consider the use of quantitative measures using commercial software tools critically, and adopt a structured disease-oriented report. In the expanding field of cognitive disorders, the only effective assessment approach is the standardized disease-oriented one, which includes a multidisciplinary integration of the clinical picture, MRI, CSF and blood biomarkers and nuclear medicine.
© 2022. The Author(s).

Entities:  

Keywords:  Assessment; Consensus; Dementia; MRI; Neuroimaging

Year:  2022        PMID: 36070064     DOI: 10.1007/s11547-022-01534-0

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   6.313


  74 in total

1.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.

Authors:  Chenjie Xia; Sara J Makaretz; Christina Caso; Scott McGinnis; Stephen N Gomperts; Jorge Sepulcre; Teresa Gomez-Isla; Bradley T Hyman; Aaron Schultz; Neil Vasdev; Keith A Johnson; Bradford C Dickerson
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

2.  Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.

Authors:  Jordi A Matías-Guiu; Carmen Guerrero-Márquez; María Nieves Cabrera-Martín; Ulises Gómez-Pinedo; María Romeral; Diego Mayo; Jesús Porta-Etessam; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu
Journal:  Prion       Date:  2017-05-16       Impact factor: 3.931

3.  Nonamnestic presentations of early-onset Alzheimer's disease.

Authors:  Mario F Mendez; Albert S Lee; Aditi Joshi; Jill S Shapira
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-07       Impact factor: 2.035

4.  Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia.

Authors:  A Harding; G Halliday; D Caine; J Kril
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

5.  Reversible brain shrinkage in abstinent alcoholics, measured by MRI.

Authors:  G Schroth; T Naegele; U Klose; K Mann; D Petersen
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

6.  Qualitative and quantitative analysis of 3D T1 Silent imaging.

Authors:  Francesca Di Giuliano; Silvia Minosse; Eliseo Picchi; Valentina Ferrazzoli; Valerio Da Ros; Massimo Muto; Chiara Adriana Pistolese; Francesco Garaci; Roberto Floris
Journal:  Radiol Med       Date:  2021-06-15       Impact factor: 3.469

7.  Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study.

Authors:  Stefan Gazdzinski; Timothy C Durazzo; Anderson Mon; Ping-Hong Yeh; Dieter J Meyerhoff
Journal:  Brain       Date:  2010-02-04       Impact factor: 13.501

8.  MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; D Collie; D M Summers; S Almonti; S J Collins; P Smith; P Cras; G H Jansen; J P Brandel; M B Coulthart; H Roberts; B Van Everbroeck; D Galanaud; V Mellina; R G Will; I Zerr
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

9.  Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.

Authors:  Reisa Sperling; Stephen Salloway; David J Brooks; Donatella Tampieri; Jerome Barakos; Nick C Fox; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Ivan Lieberburg; H Michael Arrighi; Kristen A Morris; Yuan Lu; Enchi Liu; Keith M Gregg; H Robert Brashear; Gene G Kinney; Ronald Black; Michael Grundman
Journal:  Lancet Neurol       Date:  2012-02-03       Impact factor: 44.182

10.  In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Authors:  Gregory S Day; Brian A Gordon; Richard J Perrin; Nigel J Cairns; Helen Beaumont; Katherine Schwetye; Cole Ferguson; Namita Sinha; Robert Bucelli; Erik S Musiek; Nupur Ghoshal; Maria R Ponisio; Benjamin Vincent; Shruti Mishra; Kelley Jackson; John C Morris; Tammie L S Benzinger; Beau M Ances
Journal:  Neurology       Date:  2018-02-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.